If approved, ziftomenib could be the first FDA-approved Menin inhibitor for relapsed/refractory acute myeloid leukemia with ...

An inaugural men’s health strategy for England, which is expected this year, aims to address the 4-year life expectancy gap ...

University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...